Terms: = Lung cancer AND PR, PGR, progesterone receptor AND Prognosis
270 results:
1. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of the patients with metastatic male breast cancer.
Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
4. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
Lin Y; Cao Q; Hong A; Liang X
Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
[TBL] [Abstract] [Full Text] [Related]
5. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract] [Full Text] [Related]
6. Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective.
Dai F; Chen C; Zhou G; Wang X; Mei L; Luo N; Zhou W; Li T; Deng B; Liu L; Wang Y
Thorac Cancer; 2024 Apr; 15(10):830-846. PubMed ID: 38414317
[TBL] [Abstract] [Full Text] [Related]
7. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
8. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of lymph node metastasis of lung squamous cell carcinoma by machine learning algorithm classifiers.
Li G; Li C; Liu J; Peng H; Lu S; Wei D; Guo J; Wang M; Yang N
J Cancer Res Ther; 2023 Dec; 19(6):1533-1543. PubMed ID: 38156919
[TBL] [Abstract] [Full Text] [Related]
11. progesterone receptor-Grb2 interaction is associated with better outcomes in breast cancer.
Wittayavimol N; Iwabuchi E; Pateetin P; Miki Y; Onodera Y; Sasano H; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2024 Mar; 237():106441. PubMed ID: 38070754
[TBL] [Abstract] [Full Text] [Related]
12. The Association between ER, PR, HER2, and ER-/PR+ Expression and lung cancer Subsequent in Breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
Shao HY; Hao BT; Gao FX
Breast J; 2023; 2023():7028189. PubMed ID: 38021219
[TBL] [Abstract] [Full Text] [Related]
13. Disitamab Vedotin plus anti-PD-1 antibody show good efficacy in refractory primary urethral cancer with low HER2 expression: a case report.
Zheng Y; Xue YY; Zhao YQ; Chen Y; Li ZP
Front Immunol; 2023; 14():1254812. PubMed ID: 37901233
[TBL] [Abstract] [Full Text] [Related]
14. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract] [Full Text] [Related]
15. Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Mang A; Zou W; Rolny V; Reck M; Cigoianu D; Schulze K; Holdenrieder S; Socinski MA; Shames DS; Wehnl B; Patil NS
Tumour Biol; 2024; 46(s1):S177-S190. PubMed ID: 37545290
[TBL] [Abstract] [Full Text] [Related]
16. Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial.
Wade-Mcbane K; King A; Urch C; Johansson L; Wells M
BMJ Open; 2023 Jul; 13(7):e072367. PubMed ID: 37460263
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
[TBL] [Abstract] [Full Text] [Related]
18. Socioeconomic status and cancer survival in Brazil: Analysis of population data from the municipalities of Aracaju and Curitiba, 1996-2012.
Renna Junior NL; Azevedo E Silva G
Cancer Epidemiol; 2023 Aug; 85():102394. PubMed ID: 37419053
[TBL] [Abstract] [Full Text] [Related]
19. CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/CXCR4 signaling axis in preclinical breast cancer model.
Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
[TBL] [Abstract] [Full Text] [Related]
20. The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy.
Li R; Cao L
Front Immunol; 2023; 14():1194020. PubMed ID: 37275874
[TBL] [Abstract] [Full Text] [Related]
[Next]